LANDMARK Total Knee System
Smith & Nephew, Inc. · Decision date Sep 8, 2026
What did the FDA decide?
FDA records show a 510(k) premarket notification, K261462, for the LANDMARK Total Knee System, submitted by Smith & Nephew, Inc. The listed medical specialty is Orthopedic and the product code is MBH, which the source page describes as a semi-constrained patello/femorotibial knee prosthesis. The application was received on 05/04/2026 and decided on 09/08/2026.
The recorded decision is SESE, which for a 510(k) denotes clearance rather than PMA approval. The source does not state which components, materials, sizes or labeling changes distinguish this submission, nor does it identify a predicate device or summarize the review basis. No clearance statement text, indications, or clinical data are available here, so the scope of what was cleared remains unknown beyond the listed device name and classification fields.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 8, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261462
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Smith & Nephew, Inc.
- Product code
- MBH
- Decision code
- SESE
- Decision date
- Sep 8, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer.
- Applicant
- Smith & Nephew, Inc.
- Product code
- MBH
- FDA device class
- 2
FDA decision timeline
K261462 received
Application receipt date recorded by FDA.
K261462 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MBH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Corin, Ltd. | 510(k) clearance | Sep 17, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Smith & Nephew, Inc.
- Headquarters
- Not reported
- Brand website
- smith-nephew.com
- FDA applicant address
- Memphis, TN
Sources and methodology
- Original FDA record: K261462
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records